Your browser doesn't support javascript.
loading
Prevalence of One-Year Mortality after Implantable Cardioverter Defibrillator Placement: An Opportunity for Palliative Care?
Kalver, Emily; Branch-Elliman, Westyn; Stolzmann, Kelly; Wachterman, Melissa; Shin, Marlena H; Schweizer, Marin L; Mull, Hillary J.
Afiliação
  • Kalver E; Center for Healthcare Organization and Implementation Research (CHOIR), VA Boston Healthcare System, Boston, Massachusetts, USA.
  • Branch-Elliman W; Department of Psychology, Montclair State University, Montclair, New Jersey, USA.
  • Stolzmann K; Center for Healthcare Organization and Implementation Research (CHOIR), VA Boston Healthcare System, Boston, Massachusetts, USA.
  • Wachterman M; Department of Medicine, Infectious Disease, and General Medicine, VA Boston Healthcare System, Boston, Massachusetts, USA.
  • Shin MH; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Schweizer ML; Center for Healthcare Organization and Implementation Research (CHOIR), VA Boston Healthcare System, Boston, Massachusetts, USA.
  • Mull HJ; Center for Healthcare Organization and Implementation Research (CHOIR), VA Boston Healthcare System, Boston, Massachusetts, USA.
J Palliat Med ; 26(2): 175-181, 2023 02.
Article em En | MEDLINE | ID: mdl-36067080
Background: Current guidelines recommend against placement of implantable cardioverter defibrillators in patients with a life expectancy less than one year. These patients may benefit from early palliative care services; however, identifying this population is challenging. Objective: Determine whether a validated prognostic tool, based on patient factors and health care utilization from electronic medical records, accurately predicts one-year mortality at the time of implantable cardioverter defibrillator placement. Design: We used the United States (U.S.) Veterans Administration's "Care Assessment Needs" one-Year Mortality Score to identify patients at high risk of mortality (score ≥95) before their procedure. Data were extracted from the Corporate Data Warehouse. Logistic regression was used to assess the odds of mortality at different score levels. Setting/Subjects: Patients undergoing a new implantable cardioverter defibrillator procedure between October 1, 2015 and September 30, 2017 in the U.S. Veterans Administration. Results: Of 3194 patients with a new implantable cardioverter defibrillator placed, 657 (21.8%) had a score ≥95. The mortality rate among these patients was 151/657 (22.9%) compared with 281/3194 (8.8%) for all patients undergoing a new implantable cardioverter defibrillator procedure. Patients with a score ≥95 had 14.0 (95% confidence interval 8.0-24.4) higher odds of death within one year of the procedure compared with those with a score ≤60. Conclusions: The "Care Assessment Needs" Score is a valid predictor of one-year mortality following implantable cardioverter defibrillator procedures. Integrating its use into the management of Veterans Administration (VA) patients considering implantable cardioverter defibrillators may improve shared decision making and engagement with palliative care.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desfibriladores Implantáveis / Enfermagem de Cuidados Paliativos na Terminalidade da Vida Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desfibriladores Implantáveis / Enfermagem de Cuidados Paliativos na Terminalidade da Vida Idioma: En Ano de publicação: 2023 Tipo de documento: Article